National PROMs Network(@NetworkProms) 's Twitter Profile Photo

Thank you Antoinette Davey Tim Pickles Joanne Greenhalgh 💙 and OutcomesFacilitator (PROMs) for sharing reflections of a great day looking at across the life span with our members who had been unable to attend. Bringing the ISOQOL UK & Ireland PROMs SIG and the National PROMs Network together.

Thank you @abuisman @PicklesTim  @Greenhalgh_Jo and @Outcomes_PROMs  for sharing reflections of a great day looking at #PROMs across the life span with our members who had been unable to attend. Bringing the @ISOQOL UK & Ireland PROMs SIG and the National PROMs Network together.
account_circle
National PROMs Network(@NetworkProms) 's Twitter Profile Photo

We can't wait to hear today from our members who are sharing their takeaways from the ISOQOL 30th Annual conference last month. A wonderful opportunity for academic/research and clinical sharing and building on collaboration. Members will find the link on Spond.

We can't wait to hear today from our #ISOQOL_UK members who are sharing their takeaways from the @ISOQOL 30th Annual conference last month. A wonderful opportunity for academic/research and clinical sharing and building on collaboration. Members will find the link on Spond.
account_circle
Julie Ratcliffe(@JulieRatcliff19) 's Twitter Profile Photo

Excellent current state of play overview presentation today ISOQOL from QUOKKA principal Investigator ⁦⁦nance devlin⁩ on valuation of child health related quality of life for the EQ-5DY-3L and EQ-5DY-5L ⁦QUOKKA Research Program

Excellent current state of play overview presentation today @ISOQOL #ISOQOL23 from QUOKKA principal Investigator ⁦⁦@nancydevlin1⁩ on valuation of child health related quality of life for the EQ-5DY-3L and EQ-5DY-5L ⁦@QUOKKA_Research⁩
account_circle
Diana Khanna(@diana_khanna) 's Twitter Profile Photo

The phenomenal Julie Ratcliffe presenting at the findings of an important study in the older adult population with some form of cognitive impairment investigating the reliability of self-reported HRQoL using the EQ-5D-5L 👏🏼👏🏼

The phenomenal @JulieRatcliff19 presenting at #ISOQOL the findings of an important study in the older adult population with some form of cognitive impairment investigating the reliability of self-reported HRQoL using the EQ-5D-5L 👏🏼👏🏼
account_circle
Person-centered Methods and Analytics Lab(@pcma_lab) 's Twitter Profile Photo

Our Principal Investigator, Tolu Sajobi, will deliver an oral presentation on: 'Tree-based item response theory model for testing response shift in patient-reported outcome measures: An exploratory study' on Thursday, October 19, 2023.
ISOQOL

Our Principal Investigator, @dr_sajobi, will deliver an oral presentation on: 'Tree-based item response theory model for testing response shift in patient-reported outcome measures: An exploratory study' on Thursday, October 19, 2023. 
@ISOQOL
#ISOQOL
account_circle
Jens Lehmann(@JLehmann_IBK) 's Twitter Profile Photo

💡Lessons from the electronic symptom monitoring session

Galina Velikova presenting on monitoring in lung cancer care:
1️⃣Dedicated resources needed to support PROMs during implementation and ongoing care
2️⃣ Importance of buy in from IT and hospital admin!

💡Lessons from the #ISOQOL electronic #PROM symptom monitoring session

Galina Velikova presenting on monitoring in lung cancer care:
1️⃣Dedicated resources needed to support PROMs during implementation and ongoing care
2️⃣ Importance of buy in from IT and hospital admin!
account_circle
Tim Pickles(@PicklesTim) 's Twitter Profile Photo

Presenting the results of the qualitative research on content validity for a new patient reported outcome measure for Rheumatoid Arthritis Disease Activity at the ever wonderful conference in Calgary
ISOQOL
CTRCardiffUni
Health and Care Research Wales

Presenting the results of the qualitative research on content validity for a new patient reported outcome measure for Rheumatoid Arthritis Disease Activity at the ever wonderful #ISOQOL conference in Calgary 
@ISOQOL 
@CTRCardiffUni 
@ResearchWales
account_circle
Feng Xie(@FengtasticXie) 's Twitter Profile Photo

“The role of legacy tools: is newer always better?” A brilliant and thought provoking plenary debate by Profs Andrew Finlay and John Ware 2023.

“The role of legacy tools: is newer always better?” A brilliant and thought provoking plenary debate by Profs Andrew Finlay and John Ware #ISOQOL 2023.
account_circle
National PROMs Network(@NetworkProms) 's Twitter Profile Photo

The conference may be over, but we invite @ScHARRSheffield ISOQOL Welsh Value in Health Centre @Cedar_Cardiff NIHR Yorkshire & Humber ARC members to join our own National PROMs Network members in reflecting on a great day and what we learned.
📩co-ordinators at promsnetwork.co.uk

The #UKPROMs conference may be over, but we invite @ScHARRSheffield @ISOQOL @Valuein_Health @Cedar_Cardiff @NIHR_ARC_YH  members to join our own National PROMs Network members in reflecting on a great day and what we learned.
📩co-ordinators at promsnetwork.co.uk
account_circle
Person-centered Methods and Analytics Lab(@pcma_lab) 's Twitter Profile Photo

We are pleased to share about the ISOQOL annual meeting in Calgary, Canada, between October 18–21, 2023. Join us in Calgary for this meeting and check out a few presentations to be delivered by members and collaborators of the Person-centered Methods and Analytics Lab Tolu Sajobi

We are pleased to share about the @ISOQOL annual meeting in Calgary, Canada, between October 18–21, 2023. Join us in Calgary for this meeting and check out a few presentations to be delivered by members and collaborators of the @pcma_lab @dr_sajobi
account_circle
Cecilia Pompili MD PhD FACS(@pompili_cecilia) 's Twitter Profile Photo

Reliance on clinician assessment of symptomatic toxicities can lead to an underestimation of patients’ experiences.
FDA Oncology draft guidance is a step forward , but more clarification on patient-reported tolerability is needed. Devin Peipert ISOQOL
pubmed.ncbi.nlm.nih.gov/37217665/

Reliance on clinician assessment of symptomatic toxicities can lead to an underestimation of patients’ experiences. 
@FDAOncology draft guidance is a step forward , but more clarification on patient-reported tolerability is needed. @dpeipert @ISOQOL 
pubmed.ncbi.nlm.nih.gov/37217665/
account_circle